Carrión Sari S.K., Martínez-Lostao L., Colás Sanz C., Sobrevía Elfau M.T.. Early Oral Immunotherapy With Pasteurized Egg White in Egg-Allergic Children Under 2 Years of Age. Clinical and Translational Allergy. March 2026. DOI: 10.1002/clt2.70155.

Marco-Brualla J., García-Álvarez F., Fuente S., Fernández P., Vitoria A., Vázquez F.J., Lapuente-Fernández J.P., Martínez-Lostao L., Romero A., Anel A.. The Combination of Immunomodulatory Secretome and Liposome-Bound TRAIL Improves Knee Osteoarthritis Symptoms in an Ovine Model. Pharmaceutics. February 2026. DOI: 10.3390/pharmaceutics18020193.

Pesini C., Gil-Bellido M., S Millan L., Oñate C., Calvo-Pérez A., Santiago L., Iglesias E., Bernal J.P., Araujo-Voces M., Paz Artigas L., García-Martínez L., Roig F.J., Movilla Meno N., Garcia-Aznar J.M., Menéndez-Jandula B., Olave M.T., Azaceta Reinares G., Garrote M., Alvarez-Larrán A., Gálvez E.M., Sánchez Martínez D., Arias M.A., Pardo J., Ramirez-Labrada A.. Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasms. Journal for Immunotherapy of Cancer. 13 January 2026. DOI: 10.1136/jitc-2025-012706.

Gracia Tello B.D.C., García-Bruñén J.M., Corredor L., Allue Fantova N., Calvo Beguería E.M., García-Muñío R., Pérez Abad L., Aramburu Llorente J., Martinez Muriel B., Vidales Miguélez P., Morante Mendoza R.A., Martínez Artigot J., Chicano Nieto N., Álvarez Troncoso J., Martinez-Lostao L., Marín Ballvé A.. Elevated interleukin-6 levels predict short-term flare in systemic lupus erythematosus. Frontiers in Immunology. 2026. DOI: 10.3389/fimmu.2026.1825342.

Tirado N., Fidyt K., Mansilla M.J., Garcia-Perez A., Martínez-Moreno A., Vinyoles M., Alcain J., García-Peydró M., Roca-Ho H., Fernandez-Fuentes N., Guerrero-Murillo M., Falgàs A., Velasco-Hernandez T., Bueno C., Panelli P., Mulens-Arias V., Apostolov A., Engel P., González E.A., Vick B., Jeremias I., Caye-Eude A., Baruchel A., Cavé H., Genescà E., Ribera J., Díaz-Beyá M., Martínez-Sánchez M.V., Fuster J.L., Escudero López A., Minguillón J., Pérez-Martínez A., Ramírez-Orellana M., Torrebadell M., Díaz V.M., Toribio M.L., Sánchez-Martínez D., Menéndez P.. CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia. Journal of Hematology and Oncology. December 2025. DOI: 10.1186/s13045-025-01715-0.

Pérez-Amill L., Armand-Ugón M., Val-Casals M., Martín-Herreros B., Álamo J.R., Peña S., Frigola G., Altuna A., Santos C., Guijarro F., Minguela A., Bataller À., Casanovas-Albertí B., Uribe-Herranz M., Navarro I., Guerreiro M., Sánchez-Martínez D., Tirado N., Velasco-Hernandez T., Menéndez P., Martínez A., Rovira M., Colomer D., González-Navarro E.A., Esteve J., Urbano-Ispizua Á., Montesinos P., Delgado J., Juan M., Klein-González N.. A novel chimeric antigen receptor T-cell therapy targeting CD84 for the treatment of acute myeloid and T-cell lymphoblastic leukemias. Leukemia. October 2025. DOI: 10.1038/s41375-025-02705-4.

Pesini C., Lanuza P.M., Pardo J., Sánchez-Martínez D., Ramírez-Labrada A.. Expansion and activation of NK cells supported by accessory cells. Phenotypic and functional characterization. Methods in Cell Biology. January 2025. DOI: 10.1016/bs.mcb.2025.02.003.

Esteban P., Letona-Gimenez S., Domingo M.P., Morte E., Pellejero-Sagastizabal G., Del Mar Encabo M., Ramírez-Labrada A., Sanz-Pamplona R., Pardo J., Paño J.R., Galvez E.M.. Combination of exhaled volatile organic compounds with serum biomarkers predicts respiratory infection severity. Pulmonology. 2025. DOI: 10.1080/25310429.2025.2477911.

Ramirez-Labrada A., Santiago L., Pesini C., Arrieta M., Arias M., Calvo Pérez A., Ciulla M.G., Forouharshad M., Pardo J., Gálvez E.M., Gelain F.. Multiparametric in vitro and in vivo analysis of the safety profile of self-assembling peptides. Scientific Reports. December 2024. DOI: 10.1038/s41598-024-54051-7.

García-Alvarez F., Chueca-Marco Á., Martínez-Lostao L., Aso-Gonzalvo M., Estella-Nonay R., Albareda J.. Serum levels of IL-6 and IL-10 on admission correlate with complications in elderly patients with hip fracture. Injury. October 2024. DOI: 10.1016/j.injury.2024.111736.

Redrado-Hernández S., Macías-León J., Castro-López J., Belén Sanz A., Dolader E., Arias M., González-Ramírez A.M., Sánchez-Navarro D., Petryk Y., Farkaš V., Vincke C., Muyldermans S., García-Barbazán I., del Agua C., Zaragoza O., Arroyo J., Pardo J., Gálvez E.M., Hurtado-Guerrero R.. Broad Protection against Invasive Fungal Disease from a Nanobody Targeting the Active Site of Fungal β-1,3-Glucanosyltransferases. Angewandte Chemie International Edition. 19 August 2024. DOI: 10.1002/anie.202405823.

Sesma A., Pardo J., Isla D., M. Gálvez E., Gascón-Ruiz M., Martínez-Lostao L., Moratiel A., Paño-Pardo J.R., Quílez E., Torres-Ramón I., Yubero A., Zapata-García M., Domingo M.P., Esteban P., Sanz Pamplona R., Lastra R., Ramírez-Labrada A.. Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer. Cancers. August 2024. DOI: 10.3390/cancers16162798.

Zapata-García M., Moratiel-Pellitero A., Isla D., Gálvez E., Gascón-Ruiz M., Sesma A., Barbero R., Galeano J., del Campo R., Ocáriz M., Quílez E., Cruellas M., Remírez-Labrada A., Pardo J., Martínez-Lostao L., Domingo M.P., Esteban P., Torres-Ramón I., Yubero A., Paño J.R., Lastra R.. Impact of antibiotics, corticosteroids, and microbiota on immunotherapy efficacy in patients with non-small cell lung cancer. Heliyon. 15 July 2024. DOI: 10.1016/j.heliyon.2024.e33684.

Senan-Salinas A., Comas L., Esteban P., Garzón-Tituaña M., Cheng Z., Santiago L., Domingo M.P., Ramírez-Labrada A., Paño-Pardo J.R., Vendrell M., Pardo J., Arias M.A., Galvez E.M.. Selective Detection of Active Extracellular Granzyme A by Using a Novel Fluorescent Immunoprobe with Application to Inflammatory Diseases. ACS Pharmacology and Translational Science. 10 May 2024. DOI: 10.1021/acsptsci.4c00065.

Mensurado S., Condeço C., Sánchez-Martínez D., Shirley S., Coelho R.M.L., Tirado N., Vinyoles M., Blanco-Domínguez R., Barros L., Galvão B., Custódio N., Gomes da Silva M., Menéndez P., Silva-Santos B.. CD155/PVR determines acute myeloid leukemia targeting by Delta One T cells. Blood. 11 April 2024. DOI: 10.1182/blood.2023022992.

Moratiel-Pellitero A., Zapata-García M., Gascón-Ruiz M., Sesma A., Quílez E., Ramirez-Labrada A., Martínez-Lostao L., Domingo M.P., Esteban P., Yubero A., Barbero-Herranz R., Moreno-Blanco A., Paño J.R., Lastra R., Pardo J., Isla D., del Campo R., Gálvez E.. Biomarkers of Immunotherapy Response in Patients with Non-Small-Cell Lung Cancer: Microbiota Composition, Short-Chain Fatty Acids, and Intestinal Permeability. Cancers. March 2024. DOI: 10.3390/cancers16061144.

López-Pérez J., Martínez-Lostao L., Inda-Landaluce M.. Identification of the novel HLA-C*01:65:02 allele by next-generation sequencing. Hla. February 2024. DOI: 10.1111/tan.15415.

Morte-Romea E., Pesini C., Pellejero-Sagastizábal G., Letona-Giménez S., Martínez-Lostao L., Aranda S.L., Toyas C., Redrado S., Dolader-Ballesteros E., Arias M., Galvez E.M., Sanz-Pamplona R., Pardo J., Paño-Pardo J.R., Ramírez-Labrada A.. CAR Immunotherapy for the treatment of infectious diseases: a systematic review. Frontiers in Immunology. 2024. DOI: 10.3389/fimmu.2024.1289303.

Agulló-García A., Colás Sanz C., Martínez-Lostao L., Salamanca Fernández G., Ferrer Clavería L., Cubero Saldaña J.L., Lozano Andaluz S.V., Carbajo Martínez E., Villalba Díaz M.T.. Clinical and Molecular Profiles in Patients Allergic to Amaranthaceae. Journal of Investigational Allergology and Clinical Immunology. 2024. DOI: 10.18176/jiaci.0931.

Pesini C., Artal L., Paúl Bernal J., Sánchez Martinez D., Pardo J., Ramírez-Labrada A.. In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors. Oncoimmunology. 2024. DOI: 10.1080/2162402X.2024.2379062.

Martínez-Domínguez S.J., García-Mateo S., Sainz-Arnal P., Martínez-García J., Gallego-Llera B., Lozano-Limones M.J., Hidalgo S., Gargallo-Puyuelo C.J., Latre-Santos M., Nocito-Colon M.M.L., Martínez-Lostao L., Refaie E., Arroyo-Villarino M.T., del Rio-Nechaevsky M., Ramirez-Labrada A., Pardo J., Gomollón F., Baptista P.M.. Unravelling the cellular response to the SARS-COV-2 vaccine in inflammatory bowel disease patients on biologic drugs. Scientific Reports. December 2023. DOI: 10.1038/s41598-023-50537-y.

Cheng Z., Thompson E.J., Mendive-Tapia L., Scott J.I., Benson S., Kitamura T., Senan-Salinas A., Samarakoon Y., Roberts E.W., Arias M.A., Pardo J., Galvez E.M., Vendrell M.. Fluorogenic Granzyme A Substrates Enable Real-Time Imaging of Adaptive Immune Cell Activity. Angewandte Chemie International Edition. 13 February 2023. DOI: 10.1002/anie.202216142.

Marco-Brualla J., de Miguel D., Martínez-Lostao L., Anel A.. DR5 Up-Regulation Induced by Dichloroacetate Sensitizes Tumor Cells to Lipid Nanoparticles Decorated with TRAIL. Journal of Clinical Medicine. January 2023. DOI: 10.3390/jcm12020608.

Calvo J., Santiago L., Arias M., Pardo J., Albareda J., Martínez-Lostao L., García-Alvarez F.. Granzyme-A deficiency attenuates experimental osteoarthritis in mice, but perforin deficiency does not. Joint Diseases and Related Surgery. 2023. DOI: 10.52312/jdrs.2023.892.

Gascón-Ruiz M., Ramírez-Labrada A., Lastra R., Martínez-Lostao L., Paño-Pardo J.R., Sesma A., Zapata-García M., Moratiel A., Quílez E., Torres-Ramón I., Yubero A., Domingo M.P., Esteban P., Gálvez E.M., Pardo J., Isla D.. A Subset of PD-1-Expressing CD56bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer. Cancers. January 2023. DOI: 10.3390/cancers15020329.

Jiménez-Reinoso A., Tirado N., Martinez-Moreno A., Díaz V.M., García-Peydró M., Hangiu O., Díez-Alonso L., Albitre Á., Penela P., Toribio M.L., Menéndez P., Álvarez-Vallina L., Sánchez Martínez D.. Efficient preclinical treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-CD1a T cell engagers. Journal for ImmunoTherapy of Cancer. 23 December 2022. DOI: 10.1136/jitc-2022-005333.

Martínez D.S., Tirado N., Mensurado S., Martínez-Moreno A., Romecín P., Agüera F.G., Correia D.V., Silva-Santos B., Menéndez P.. Generation and proof-of-concept for allogeneic CD123 CAR-Delta One T (DOT) cells in acute myeloid leukemia. Journal for ImmunoTherapy of Cancer. 26 September 2022. DOI: 10.1136/jitc-2022-005400.

Villanueva-Saz S., Martinez-Lostao L., Yzuel A., Fernández A., Verde M.. Selective IgA deficiency and presumptive polyclonal spike in the beta fraction in a dog with leishmaniosis. Veterinary Record Case Reports. September 2022. DOI: 10.1002/vrc2.412.

de Miguel D., Ramirez-Labrada A., Uranga I., Hidalgo S., Santiago L., Galvez E.M., Arias M., Pardo J.. Inflammatory cell death induced by cytotoxic lymphocytes: a dangerous but necessary liaison. FEBS Journal. August 2022. DOI: 10.1111/febs.16093.

Soler-Agesta R., Guerrero-Ochoa P., Marco-Brualla J., Ibáñez-Pérez R., Marzo I., Martínez-Lostao L., Anel A.. Conjugation of the 9-kDa Isoform of Granulysin with Liposomes Potentiates Its Cytotoxicity. International Journal of Molecular Sciences. August 2022. DOI: 10.3390/ijms23158705.

Lanuza P.M., Alonso M.H., Hidalgo S., Uranga-Murillo I., García-Mulero S., Arnau R., Santos C., Sanjuan X., Santiago L., Comas L., Redrado S., Pazo-Cid R., Agustin-Ferrández M.J., Jaime-Sánchez P., Pesini C., Gálvez E.M., Ramírez-Labrada A., Arias M., Sanz-Pamplona R., Pardo J.. Adoptive NK Cell Transfer as a Treatment in Colorectal Cancer Patients: Analyses of Tumour Cell Determinants Correlating With Efficacy In Vitro and In Vivo. Frontiers in Immunology. 7 June 2022. DOI: 10.3389/fimmu.2022.890836.

Ramírez-Labrada A., Pesini C., Santiago L., Hidalgo S., Calvo-Pérez A., Oñate C., Andrés-Tovar A., Garzón-Tituaña M., Uranga-Murillo I., Arias M.A., Galvez E.M., Pardo J.. All About (NK Cell-Mediated) Death in Two Acts and an Unexpected Encore: Initiation, Execution and Activation of Adaptive Immunity. Frontiers in Immunology. 16 May 2022. DOI: 10.3389/fimmu.2022.896228.

Redrado S., Esteban P., Domingo M.P., Lopez C., Rezusta A., Ramirez-Labrada A., Arias M., Pardo J., Galvez E.M.. Integration of In Silico and In Vitro Analysis of Gliotoxin Production Reveals a Narrow Range of Producing Fungal Species. Journal of Fungi. April 2022. DOI: 10.3390/jof8040361.

Zanetti S.R., Velasco-Hernandez T., Gutierrez-Agüera F., Díaz V.M., Romecín P.A., Roca-Ho H., Sánchez-Martínez D., Tirado N., Baroni M.L., Petazzi P., Torres-Ruiz R., Molina O., Bataller A., Fuster J.L., Ballerini P., Juan M., Jeremias I., Bueno C., Menéndez P.. A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL. Molecular Therapy. 2 February 2022. DOI: 10.1016/j.ymthe.2021.08.033.

Gracia B.D.C., Sáez L., Pallarés L., Velilla J., Marín A., Martinez-Lostao L., Simeón C.P., Fanlo P.. COVID GEAS: COVID-19 National Survey in Patients With Systemic Autoimmune Diseases. Frontiers in Medicine. 27 January 2022. DOI: 10.3389/fmed.2021.808608.

Uranga-Murillo I., Morte E., Hidalgo S., Pesini C., García-Mulero S., Sierra J.L., Santiago L., Arias M., de Miguel D., del Mar Encabo-Berzosa M., Gracia-Tello B., Sanz-Pamplona R., Martinez-Lostao L., Galvez E.M., Paño-Pardo J.R., Ramirez-Labrada A., Pardo J.. Integrated analysis of circulating immune cellular and soluble mediators reveals specific COVID19 signatures at hospital admission with utility for prediction of clinical outcomes. Theranostics. 2022. DOI: 10.7150/THNO.63463.

Pesini C., Hidalgo S., Arias M.A., Santiago L., Calvo C., Ocariz-Díez M., Isla D., Lanuza P.M., Agustín M.J., Galvez E.M., Ramírez-Labrada A., Pardo J.. PD-1 is expressed in cytotoxic granules of NK cells and rapidly mobilized to the cell membrane following recognition of tumor cells. Oncoimmunology. 2022. DOI: 10.1080/2162402X.2022.2096359.

Cruellas M., Yubero A., Zapata M., Galvez E.M., Gascón M., Isla D., Lastra R., Martínez-Lostao L., Ocariz M., Pardo J., Ramírez A., Sesma A., Torres-Ramón I., Paño J.R.. How could antibiotics, probiotics, and corticoids modify microbiota and its influence in cancer immune checkpoint inhibitors: A review. Infection and Immunity. September 2021. DOI: 10.1128/IAI.00665-20.

Rubio-Gracia J., Giménez-López I., Garcés-Horna V., López-Delgado D., Sierra-Monzón J.L., Martínez-Lostao L., Josa-Laorden C., Ruiz-Laiglesia F., Pérez-Calvo J.I., Crespo-Aznarez S., García-Lafuente J., Fresneda N.P., Arriaga B.A., Gracia-Tello B., Sánchez-Marteles M.. Point-of-care lung ultrasound assessment for risk stratification and therapy guiding in COVID-19 patients: A prospective noninterventional study. European Respiratory Journal. 1 September 2021. DOI: 10.1183/13993003.04283-2020.

Sánchez-Marteles M., Rubio-Gracia J., Peña-Fresneda N., Garcés-Horna V., Gracia-Tello B., Martínez-Lostao L., Crespo-Aznárez S., Pérez-Calvo J.I., Giménez-López I.. Early measurement of blood sst2 is a good predictor of death and poor outcomes in patients admitted for covid-19 infection. Journal of Clinical Medicine. 2 August 2021. DOI: 10.3390/jcm10163534.

Santiago L., Uranga-Murillo I., Arias M., González-Ramírez A.M., Macías-León J., Moreo E., Redrado S., García-García A., Taleb V., Lira-Navarrete E., Hurtado-Guerrero R., Aguilo N., Encabo-Berzosa M.D.M., Hidalgo S., Galvez E.M., Ramirez-Labrada A., de Miguel D., Benito R., Miranda P., Fernández A., Domingo J.M., Serrano L., Yuste C., Villanueva-Saz S., Paño-Pardo J.R., Pardo J.. Determination of the concentration of igg against the spike receptor-binding domain that predicts the viral neutralizing activity of convalescent plasma and serum against sars-cov-2. Biology. March 2021. DOI: 10.3390/biology10030208.

Llisterri J.L., Micó-Pérez R.M., Velilla-Zancada S., Rodríguez-Roca G.C., Prieto-Díaz M.Á., Martín-Sánchez V., Barquilla A., Polo-García J., Segura-Fragoso A., Cinza-Sanjurjo S., García A.B., Rodríguez Á.D., Cervantes C.E., Moreno F.J.A., Roca G.C.R., Martín J.V., Caro J.L.L., Badimón J.J., García J.P., Padial L.R., Prieto M.Á., Pérez R.V., Sanjurjo S.C., Jiménez S.M., Zancada S.V., Téllez A.L., de Los Ángeles Ortega Osuna M., Cid C.P., Fajardo M.J.H., Serna J.L., Requena Á.D., Cañizares R.A., Peña M.R., Collado F.H., Vázquez M.M., Garrido R.Á.C., Lozano M.R.H., Oliva B.O., Anguita F.J., Ibáñez C.P., Rodríguez C.A.C., Rodríguez M.J.C., Ruiz S.B., González R.R., Sánchez S.A., Martínez I.S., Jordán R.S., Navas-Parejo J.M.R., Torres J.M.R., Poveda J.M.B., Benayas M.A.d.C., Gil C.F., Alcaine J.I.E., Quintero A.M., Cepas F.L., Martín J.L.C., Criado E.G., Blanco M.V., Ortiz I.M., Mendoza L.G., Rodríguez J.C.A., Rodríguez E.M.R., Vázquez J.A., Ballesteros J.G.G., Lara M.d.L.P.F., Moreno P.A., Maturana E.P., Expósito J.M.I., Peñas N.C., Faya C.M.A., Duque A.M.A., Camisón R.T., Polo P.M., García M.P., Fernández C.L., Torres A.E., Jansen M.G., González E.L., Matarin L.G., Luna E.J.G.d., Rivero J.B., Gómez González M.J., Montes C.G., Calvo E.T., Calvo C.B., Natividad S.L.d.L., Lambea G.G., Marín E.J., Gonzalvo A.C.N., Martínez Barseló A.P., León I.P., Fernández E.L.G., Mantecón F.A., Garrido A.B.G., Escalante A.V., Rentería L.A., Jiménez J.S., Alles G.P., Garrote J.A.D., Sotodosos P.M., Fuster J.A.V., Palencia M.G., Moraleda J.A.T., Ballesteros S.G., Adrados A.C.G., Cabrera A.G., Fernández M.Á.B., García G.R., Criado-Álvarez J.J., Moreno P.T., Aguirregaviria F.J.A., Martínez A.S., Béjar L.M.S., Peralta M.L., Castro R.P., Altozano C.S., Polo L.G.T., Maresca P.V., Santana R.M., Ledesma N.E.T., Espada N.G., Calvi G.D.R.Z., Montero J.L.G., Gil J.I.L., Ortega M.D.F., Roncal M.E., Serrano M.A.L., Fuente N.E.A.d.L., Larrea B.A.F.d., Fernández N.C., Gómez G.L.F., Rodríguez D.G., Tuñón S.M.A., González M.A., Olea S.d.A., Regueras J.J.L., Nieto C.M.G., Mallada D.V., García M.d.L.O.G., Rodríguez P.B., García J.I.F., Martínez B.D.d.R., Pérez A.A., Atoui O.M., Bayón Á.M., Olmo M.T.A.d., Herreros F.J.G.N., Rodríguez E.M., Pineda D.M.N., Rodríguez A.D., Ainaga V.O., Guevara M.S.S., Ferreiro L.V., Grande M.T.G., Gracía F.V.M., García M.D.M., Muñoz B.J., Marcelino G.R., Valverde D.E.F., Bernadó R.R., Lupiáñez M.T.O., Najih N., Parra J.M.D., Acebo M.R.B., Vicien M.L.B., Estella A.R.L., Gómez J.A.M., Muntané A.M., Abarca I.O., Fargas A.G., Escudero B.E.R., Riesgo S.E., Castellvi E.Z., Sagarra C.C., Fernández M.H., Presas J.A., Pérez I.D., García R.M.A., Collado I.M., Martínez R.G., Villanueva M.J.G., Martínez T.R., Pena L.P., Royo J.M.P., Gil I.G., Montero A.C., Gómez M.d.M.Z., Cebrián E.A., Acin M.J.P., Sacristán C.P., Vicente M.S.M., Unanua M.P.P., Henrich N.M., Monreal S.G., Pedro S.R.d., Pozo B.S., Martínez I.M., Uriarte B.L., Velasco C.S., Aguirre A.G., Teijido M.R., Jaén G.R., Pascual-Salcedo J.I.A., Gallego J.V., Rodilla J.C., Herrera A., Martínez E.A., Calvo A.M.G., Oliva P.M., Béjar M.M.G., Hitos J.A.H., Vallejo O.G., Vargas M.d.J.F., Boguerin M.J.C., Lerin A.G., Tablado M.Á.M., García E.C.G., Acero L.d.M., Oñate C.Z., Apoita A.B., Belloso M.E.M., Velasco A.M.H., Jiménez R.S., Pascual J.N.G., Zuluaga M.C.Z., Perez M.C.D., García A.R., Jelsbak C.M., Oria V.L., Gamarra A.G., Fuster V.P., Bort M.D.A., Gómez N.V., Gasco C.L., Barber T.A., Cano P.A.M., Moncho M.M., Muñoz M.J.L., Hernández R.N., Egea F.J.M., Tramontano A., Royo M.F., Saura B.P., Torres J.A.C., Moliner J.M.T., Penalba A.S., Alberola A.C., Ros F.M.N.I., Llicer E.B., Novás A.S., Valls I.M., Mahiques G.V., Forcada E.P., Gómez N.A., García F.J.S., Bueso M.D.P., Romero M.E.A., Camus A.F., Peinado M.A.A., Santos R.L., Marín M.A.P., García M.C.B., Fresquet E.S., Paños P.S., Ruiz T.S., Valero R.A.V., Vicente M.S., Llinares M.M., Alegre A.M., Verdú I.L., Carratala V.P., Roca F.V., Pérez R.M.M., García J.E., Romo J.I.P., Fernández L.F., Sierratapia J., Regidor N.M., Sánchez F.J.Z., Moreno A.M., Barrera F.C., Vázquez J.J.T., Samino M.J.G., Rodríguez M.Á.d.S., Martínez P.R.G., Becerra A.C.E., Olivera J.S., Cambero V., Ávila J.D., Fuentes A.S., Jiménez J.M.d.N., Fraile D.I., Barco G.N., Ramos I.A., Berrocal M.L.S., Ramírez F.B., Marcos M.G., González F.S., Carrasco V.C., Peguero F.G., Vega F.J.S., Mas M.T., Donoso A.P., Yedro M.T., Rojas M.B.E., Moreno F.C., Saldaña N.E.Q., Fenés M.d.M.G., Florencio T.G., Toro J.M.F., Rañal A.R., Río E.G.d., Pol E.N., Fernández J.Á., Álvarez P.A., Gómez M.L.J., Guerrero A.C., Colomina I.C., Casal L.B., Moreno J.F., Martínez M.A.C., Rodríguez N.D., Paredes C.M., García D.R., Mato F.J.I., Ulloa A.F., González A.F., Parada N.D., Sabarís P.C., Pérez A.I.R., Palacio A.I.G., Varela V.J.Q., Iglesias L.R., Llerena Á.L., Rodríguez C.L., Diaz M.L.C., Arias J.C., Camino J.L.V., Penas M.d.C.T., Freire S.Y., Aldana D.R., Díaz C.P., Romanos F.G., González A.M., Sastre M.L.A., Palli S.M., Bauza J.A.R., Bolinches J.O., Fernández C.F., Vázquez M.I.O., Mezquita A.S., Aramburu F.U., Morant J.F.P., Amengual A.M., García I.G., Sevillano F.R., González M.I.G., Souto M.P., Contreras R.d.L., González S.I.A., Diez I.A., Sánchez V.M.M., Lavado F.J.E., Pérez Y.A., Hernández N.S., Jerez J.L.A., Koch R., Mendoza N.R., Hernández H.S., Escobar F.J.M., Zancada S.M.V., Sabarís R.C., Jiménez Ó.F.I., Puga J.M.G., Ávila J.A.B., González Ó.d.T., Íñigo L.S., Pérez I.S., Nubla J.F.Z., Ituiño A.E., Tris G.M., Bosch M.C.N., González E., Macho M.L.R., Olmo R.S.d., Prado A.O.d., Muguerza A.L.d.V., Iriso J.I., Martínez M.J.P., Carbonell A.P., Fernández M.A., Cuadrado M.M.R., Rodríguez R.A., Cabo J.M.Á., Rodríguez R.S., Cabo E.M.C., Secin A.R., Díaz M.Á.P., Fernández J.J.G., Bueno V.L., Pérez A.M.B., López D.J.R., Franco M.D.E., Pablo E.S., López M.T.P., Meroño J.C., Martínez J.M.L., Martínez I.M.P., Carrasco J.E.C., González A.S.. Prevalence of chronic kidney disease and associated factors in the Spanish population attended in primary care: Results of the IBERICAN study. Medicina Clinica. 26 February 2021. DOI: 10.1016/j.medcli.2020.03.005.

Esteban P., Redrado S., Comas L., Domingo M.P., Millán-Lou M.I., Seral C., Algarate S., Lopez C., Rezusta A., Pardo J., Arias M., Galvez E.M.. In Vitro and In Vivo Antibacterial Activity of Gliotoxin Alone and in Combination with Antibiotics against Staphylococcus aureus. Toxins. February 2021. DOI: 10.3390/TOXINS13020085.

Garzón-Tituaña M., Sierra-Monzón J.L., Comas L., Santiago L., Khaliulina-Ushakova T., Uranga-Murillo I., Ramirez-Labrada A., Tapia E., Morte-Romea E., Algarate S., Couty L., Camerer E., Bird P.I., Seral C., Luque P., Paño-Pardo J.R., Galvez E.M., Pardo J., Arias M.. Granzyme A inhibition reduces inflammation and increases survival during abdominal sepsis. Theranostics. 30 January 2021. DOI: 10.7150/THNO.49288.

Uranga-Murillo I., Tapia E., Garzón-Tituaña M., Ramirez-Labrada A., Santiago L., Pesini C., Esteban P., Roig F.J., Galvez E.M., Bird P.I., Pardo J., Arias M.. Biological relevance of Granzymes A and K during E. coli sepsis. Theranostics. 2021. DOI: 10.7150/thno.59418.

Al-Wasaby S., Guerrero-Ochoa P., Ibáñez-Pérez R., Soler R., Conde B., Martínez-Lostao L., Anel A.. In vivo potential of recombinant granulysin against human melanoma. Cancer Treatment and Research Communications. January 2021. DOI: 10.1016/j.ctarc.2021.100355.

Calvo T., Reina-Ortiz C., Giraldos D., Gascón M., Woods D., Asenjo J., Marco-Brualla J., Azaceta G., Izquierdo I., Palomera L., Sánchez-Martínez D., Marzo I., Naval J., Vilches C., Villalba M., Anel A.. Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance. Scientific Reports. December 2020. DOI: 10.1038/s41598-020-76051-z.

Sesma A., Pardo J., Cruellas M., Gálvez E.M., Gascón M., Isla D., Martínez-Lostao L., Ocáriz M., Paño J.R., Quílez E., Ramírez A., Torres-Ramón I., Yubero A., Zapata M., Lastra R.. From tumor mutational burden to blood T cell receptor: Looking for the best predictive biomarker in lung cancer treated with immunotherapy. Cancers. October 2020. DOI: 10.3390/cancers12102974.

Ocáriz-Díez M., Cruellas M., Gascón M., Lastra R., Martínez-Lostao L., Ramírez-Labrada A., Paño J.R., Sesma A., Torres I., Yubero A., Pardo J., Isla D., Gálvez E.M.. Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy. Frontiers in Oncology. 24 September 2020. DOI: 10.3389/fonc.2020.568939.

Piñol R., Zeler J., Brites C.D.S., Gu Y., Téllez P., Carneiro Neto A.N., Da Silva T.E., Moreno-Loshuertos R., Fernandez-Silva P., Gallego A.I., Martinez-Lostao L., Martínez A., Carlos L.D., Millán A.. Real-Time Intracellular Temperature Imaging Using Lanthanide-Bearing Polymeric Micelles. Nano Letters. 9 September 2020. DOI: 10.1021/acs.nanolett.0c02163.

Velasco-Hernandez T., Zanetti S.R., Roca-Ho H., Gutierrez-Aguera F., Petazzi P., Sánchez-Martínez D., Molina O., Baroni M.L., Fuster J.L., Ballerini P., Bueno C., Fernandez-Fuentes N., Engel P., Menendez P.. Efficient elimination of primary B-ALL cells in vitro and in vivo using a novel 4-1BB-based CAR targeting a membrane-distal CD22 epitope. Journal for ImmunoTherapy of Cancer. 11 August 2020. DOI: 10.1136/jitc-2020-000896.

Santiago L., Castro M., Sanz-Pamplona R., Garzón M., Ramirez-Labrada A., Tapia E., Moreno V., Layunta E., Gil-Gómez G., Garrido M., Peña R., Lanuza P.M., Comas L., Jaime-Sanchez P., Uranga-Murillo I., del Campo R., Pelegrín P., Camerer E., Martínez-Lostao L., Muñoz G., Uranga J.A., Alcalde A., Galvez E.M., Ferrandez A., Bird P.I., Metkar S., Arias M.A., Pardo J.. Extracellular Granzyme A Promotes Colorectal Cancer Development by Enhancing Gut Inflammation. Cell Reports. 7 July 2020. DOI: 10.1016/j.celrep.2020.107847.

Garzón-Tituaña M., Arias M.A., Sierra-Monzón J.L., Morte-Romea E., Santiago L., Ramirez-Labrada A., Martinez-Lostao L., Paño-Pardo J.R., Galvez E.M., Pardo J.. The Multifaceted Function of Granzymes in Sepsis: Some Facts and a Lot to Discover. Frontiers in Immunology. 17 June 2020. DOI: 10.3389/fimmu.2020.01054.

Baroni M.L., Martinez D.S., Aguera F.G., Ho H.R., Castella M., Zanetti S.R., Hernandez T.V., de la Guardia R.D., Castaño J., Anguita E., Vives S., Nomdedeu J., Lapillone H., Bras A.E., van der Velden V.H.J., Junca J., Marin P., Bataller A., Esteve J., Vick B., Jeremias I., Lopez A., Sorigue M., Bueno C., Menendez P.. 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo. Journal for ImmunoTherapy of Cancer. 10 June 2020. DOI: 10.1136/jitc-2020-000845.

Gascón M., Isla D., Cruellas M., Gálvez E.M., Lastra R., Ocáriz M., Paño J.R., Ramírez A., Sesma A., Torres-Ramón I., Yubero A., Pardo J., Martínez-Lostao L.. Intratumoral versus circulating lymphoid cells as predictive biomarkers in lung cancer patients treated with immune checkpoint inhibitors: Is the easiest path the best one?. Cells. June 2020. DOI: 10.3390/cells9061525.

Ramírez-Labrada A.G., Isla D., Artal A., Arias M., Rezusta A., Pardo J., Gálvez E.M.. The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy. Trends in Cancer. February 2020. DOI: 10.1016/j.trecan.2019.12.007.

Miguel D.D., Gallego-Lleyda A., Martinez-Ara M., Plou J., Anel A., Martinez-Lostao L.. Double-edged lipid nanoparticles combining liposome-bound TRAIL and encapsulated doxorubicin showing an extraordinary synergistic pro-apoptotic potential. Cancers. December 2019. DOI: 10.3390/cancers11121948.

Ibáñez-Pérez R., Guerrero-Ochoa P., Al-Wasaby S., Navarro R., Tapia-Galisteo A., De Miguel D., Gonzalo O., Conde B., Martínez-Lostao L., Hurtado-Guerrero R., Sanz L., Anel A.. Anti-tumoral potential of a human granulysin-based, CEA-targeted cytolytic immunotoxin. Oncoimmunology. 2 November 2019. DOI: 10.1080/2162402X.2019.1641392.

Bueno C., Velasco-Hernandez T., Gutiérrez-Agüera F., Zanetti S.R., Baroni M.L., Sánchez-Martínez D., Molina O., Closa A., Agraz-Doblás A., Marín P., Eyras E., Varela I., Menéndez P.. CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity. Leukemia. 1 August 2019. DOI: 10.1038/s41375-019-0418-8.

Ochoa M.C., Perez-Ruiz E., Minute L., Oñate C., Perez G., Rodriguez I., Zabaleta A., Alignani D., Fernandez-Sendin M., Lopez A., Muntasell A., Sanmamed M.F., Paiva B., Lopez-Botet M., Berraondo P., Melero I.. Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells. Oncoimmunology. 3 July 2019. DOI: 10.1080/2162402X.2019.1599636.

Marco-Brualla J., Al-Wasaby S., Soler R., Romanos E., Conde B., Justo-Méndez R., Enríquez J.A., Fernández-Silva P., Martínez-Lostao L., Villalba M., Moreno-Loshuertos R., Anel A.. Mutations in the ND2 subunit of mitochondrial complex I are sufficient to confer increased tumorigenic and metastatic potential to cancer cells. Cancers. July 2019. DOI: 10.3390/cancers11071027.

Lopez-Millan B., Sanchéz-Martínez D., Roca-Ho H., Gutiérrez-Agüera F., Molina O., Diaz de la Guardia R., Torres-Ruiz R., Fuster J.L., Ballerini P., Suessbier U., Nombela-Arrieta C., Bueno C., Menéndez P.. NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia. Leukemia. 1 July 2019. DOI: 10.1038/s41375-018-0353-0.

Sánchez-Martínez D., Baroni M.L., Gutierrez-Agüera F., Roca-Ho H., Blanch-Lombarte O., González-García S., Torrebadell M., Junca J., Ramírez-Orellana M., Velasco-Hernández T., Bueno C., Fuster J.L., Prado J.G., Calvo J., Uzan B., Cools J., Camos M., Pflumio F., Toribio M.L., Menéndez P.. Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia. Blood. 23 May 2019. DOI: 10.1182/blood-2018-10-882944.

Naval J., Miguel D.D., Lleyda A.G., Anel A., Lostao L.M.. Importance of trail molecular anatomy in receptor oligomerization and signaling. Implications for cancer therapy. Cancers. April 2019. DOI: 10.3390/cancers11040444.

Comas L., Polo E., Domingo M.P., Hernández Y., Arias M., Esteban P., Martínez-Lostao L., Pardo J., de la Fuente J.M., Gálvez E.M.. Intracellular delivery of biologically-active fungal metabolite gliotoxin using magnetic nanoparticles. Materials. 2019. DOI: 10.3390/ma12071092.

Anel A., Gallego-Lleyda A., de Miguel D., Naval J., Martínez-Lostao L.. Role of exosomes in the regulation of t-cell mediated immune responses and in autoimmune disease. Cells. 2019. DOI: 10.3390/cells8020154.

Arias M., Santiago L., Vidal-García M., Redrado S., Lanuza P., Comas L., Domingo M.P., Rezusta A., Gálvez E.M.. Preparations for invasion: Modulation of host lung immunity during pulmonary aspergillosis by gliotoxin and other fungal secondary metabolites. Frontiers in Immunology. 6 November 2018. DOI: 10.3389/fimmu.2018.02549.

Rodriguez J., Castañón E., Perez-Gracia J.L., Rodriguez I., Viudez A., Alfaro C., Oñate C., Perez G., Rotellar F., Inogés S., López-Diaz De Cerio A., Resano L., Ponz-Sarvise M., Rodriguez-Ruiz M.E., Chopitea A., Vera R., Melero I.. A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis. Journal for ImmunoTherapy of Cancer. 29 September 2018. DOI: 10.1186/s40425-018-0405-z.

Vidal-García M., Redrado S., Domingo M.P., Marquina P., Colmenarejo C., Meis J.F., Rezusta A., Pardo J., Galvez E.M.. Production of the invasive aspergillosis biomarker bis(methylthio)gliotoxin Within the genus aspergillus: In vitro and in vivo metabolite quantification and genomic analysis. Frontiers in Microbiology. 12 June 2018. DOI: 10.3389/fmicb.2018.01246.

Gallego-Lleyda A., De Miguel D., Anel A., Martinez-Lostao L.. Lipid nanoparticles decorated with TNF-related aptosis-inducing ligand (TRAIL) are more cytotoxic than soluble recombinant TRAIL in sarcoma. International Journal of Molecular Sciences. 13 May 2018. DOI: 10.3390/ijms19051449.

Rodríguez-Ruiz M.E., Perez-Gracia J.L., Rodríguez I., Alfaro C., Oñate C., Pérez G., Gil-Bazo I., Benito A., Inogés S., López-Diaz de Cerio A., Ponz-Sarvise M., Resano L., Berraondo P., Barbés B., Martin-Algarra S., Gúrpide A., Sanmamed M.F., de Andrea C., Salazar A.M., Melero I.. Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients. Annals of Oncology. 1 May 2018. DOI: 10.1093/annonc/mdy089.

Lanuza P.M., Vigueras A., Olivan S., Prats A.C., Costas S., Llamazares G., Sanchez-Martinez D., Ayuso J.M., Fernandez L., Ochoa I., Pardo J.. Activated human primary NK cells efficiently kill colorectal cancer cells in 3D spheroid cultures irrespectively of the level of PD-L1 expression. Oncoimmunology. 3 April 2018. DOI: 10.1080/2162402X.2017.1395123.

Sanchez-Martinez D., Allende-Vega N., Orecchioni S., Talarico G., Cornillon A., Vo D.N., Rene C., Lu Z.Y., Krzywinska E., Anel A., Galvez E.M., Pardo J., Robert B., Martineau P., Hicheri Y., Bertolini F., Cartron G., Villalba M.. Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors. Theranostics. 2018. DOI: 10.7150/thno.25149.

Martinez-Lostao L., de Miguel D., Anel A., Naval J.. APO2L/TRAIL. Encyclopedia of Signaling Molecules Second Edition. 1 January 2018. DOI: 10.1007/978-3-319-67199-4_2.

Núñez D., Comas L., Lanuza P.M., Sánchez-Martinez D., Pérez-Hernández M., Catalán E., Domingo M.P., Velázquez-Campoy A., Pardo J., Gálvez E.M.. A functional analysis on the interspecies interaction between mouse LFA-1 and human intercellular adhesion molecule-1 at the cell level. Frontiers in Immunology. 21 December 2017. DOI: 10.3389/fimmu.2017.01817.

Virumbrales-Muñoz M., Ayuso J.M., Olave M., Monge R., De Miguel D., Martínez-Lostao L., Le Gac S., Doblare M., Ochoa I., Fernandez L.J.. Multiwell capillarity-based microfluidic device for the study of 3D tumour tissue-2D endothelium interactions and drug screening in co-culture models. Scientific Reports. 1 December 2017. DOI: 10.1038/s41598-017-12049-4.

Alfaro C., Sanmamed M.F., Rodríguez-Ruiz M.E., Teijeira Á., Oñate C., González Á., Ponz M., Schalper K.A., Pérez-Gracia J.L., Melero I.. Interleukin-8 in cancer pathogenesis, treatment and follow-up. Cancer Treatment Reviews. November 2017. DOI: 10.1016/j.ctrv.2017.08.004.

Pérez-Hernández M., Moros M., Stepien G., del Pino P., Menao S., de las Heras M., Arias M., Mitchell S.G., Pelaz B., Gálvez E.M., de la Fuente J.M., Pardo J.. Multiparametric analysis of anti-proliferative and apoptotic effects of gold nanoprisms on mouse and human primary and transformed cells, biodistribution and toxicity in vivo. Particle and Fibre Toxicology. 26 October 2017. DOI: 10.1186/s12989-017-0222-4.

Jaime P., García-Guerrero N., Estella R., Pardo J., García-Álvarez F., Martinez-Lostao L.. CD56+/CD16− Natural Killer cells expressing the inflammatory protease granzyme A are enriched in synovial fluid from patients with osteoarthritis. Osteoarthritis and Cartilage. October 2017. DOI: 10.1016/j.joca.2017.06.007.

Sanmamed M.F., Perez-Gracia J.L., Schalper K.A., Fusco J.P., Gonzalez A., Rodriguez-Ruiz M.E., Oñate C., Perez G., Alfaro C., Martín-Algarra S., Andueza M.P., Gurpide A., Morgado M., Wang J., Bacchiocchi A., Halaban R., Kluger H., Chen L., Sznol M., Melero I.. Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients. Annals of Oncology. 1 August 2017. DOI: 10.1093/annonc/mdx190.

Arias M., Martínez-Lostao L., Santiago L., Ferrandez A., Granville D.J., Pardo J.. The Untold Story of Granzymes in Oncoimmunology: Novel Opportunities with Old Acquaintances. Trends in Cancer. June 2017. DOI: 10.1016/j.trecan.2017.04.001.

Santiago L., Menaa C., Arias M., Martin P., Jaime-Sánchez P., Metkar S., Comas L., Erill N., Gonzalez-Rumayor V., Esser E., Galvez E.M., Raja S., Simon M.M., Sprague S.M., Gabay C., Martinez-Lostao L., Pardo J., Froelich C.J.. Granzyme A Contributes to Inflammatory Arthritis in Mice Through Stimulation of Osteoclastogenesis. Arthritis and Rheumatology. 1 February 2017. DOI: 10.1002/art.39857.

Vidal-García M., Sánchez-Chueca P., Domingo M.P., Ballester C., Roc L., Ferrer I., Revillo M.J., Pardo J., Gálvez E.M., Rezusta A.. Disseminated aspergillosis in an immunocompetent patient with detectable bis(methylthio)gliotoxin and negative galactomannan. Revista Iberoamericana De Micologia. 1 January 2017. DOI: 10.1016/j.riam.2016.05.007.

Pawlak A., Miguel D.D.E., Kutkowska J., Obmińska-Mrukowicz B., Rapak A., Lostao L.M.. Flavopiridol Strongly Sensitizes Canine Lymphoma Cells to TRAIL-induced Apoptosis. Anticancer Research. 2017. DOI: 10.21873/anticanres.12123.

De Miguel D., Gallego-Lleyda A., Ayuso J.M., Pejenaute-Ochoa D., Jarauta V., Marzo I., Fernández L.J., Ochoa I., Conde B., Anel A., Martinez-Lostao L.. High-order TRAIL oligomer formation in TRAIL-coated lipid nanoparticles enhances DR5 cross-linking and increases antitumour effect against colon cancer. Cancer Letters. 28 December 2016. DOI: 10.1016/j.canlet.2016.10.005.

Jarauta V., Jaime P., Gonzalo O., de Miguel D., Ramírez-Labrada A., Martínez-Lostao L., Anel A., Pardo J., Marzo I., Naval J.. Inhibition of autophagy with chloroquine potentiates carfilzomib-induced apoptosis in myeloma cells in vitro and in vivo. Cancer Letters. 1 November 2016. DOI: 10.1016/j.canlet.2016.08.019.

Sánchez-Martínez D., Lanuza P.M., Gómez N., Muntasell A., Cisneros E., Moraru M., Azaceta G., Anel A., Martínez-Lostao L., Villalba M., Palomera L., Vilches C., García Marco J.A., Pardo J.. Activated allogeneic NK cells preferentially kill poor prognosis B-cell chronic lymphocytic leukemia cells. Frontiers in Immunology. 27 October 2016. DOI: 10.3389/fimmu.2016.00454.

Alfaro C., Teijeira A., Oñate C., Perez G., Sanmamed M.F., Andueza M.P., Alignani D., Labiano S., Azpilikueta A., Rodriguez-Paulete A., Garasa S., Fusco J.P., Aznar A., Inoges S., De Pizzol M., Allegretti M., Medina-Echeverz J., Berraondo P., Perez-Gracia J.L., Melero I.. Tumor-Produced Interleukin-8 Attracts human myeloid-derived suppressor cells and elicits extrusion of Neutrophil Extracellular Traps (NETs). Clinical Cancer Research. 1 August 2016. DOI: 10.1158/1078-0432.CCR-15-2463.

Bosque A., Dietz L., Gallego-Lleyda A., Sanclemente M., Iturralde M., Naval J., Alava M.A., Martínez-Lostao L., Thierse H.J., Anel A.. Comparative proteomics of exosomes secreted by tumoral Jurkat T cells and normal human T cell blasts unravels a potential tumorigenic role for valosin-containing protein. Oncotarget. 17 May 2016. DOI: 10.18632/oncotarget.8678.

De Miguel D., Lemke J., Anel A., Walczak H., Martinez-Lostao L.. Onto better TRAILs for cancer treatment. Cell Death and Differentiation. 1 May 2016. DOI: 10.1038/cdd.2015.174.

de Miguel D., Gallego-Lleyda A., Ayuso J.M., Pawlak A., Conde B., Ochoa I., Fernández L.J., Anel A., Martinez-Lostao L.. Improved anti-tumor activity of novel highly bioactive liposome-bound TRAIL in breast cancer cells. Recent Patents on Anti Cancer Drug Discovery. 1 April 2016. DOI: 10.2174/1574892811666160229121544.

De Miguel D., Gallego-Lleyda A., Ayuso J.M., Erviti-Ardanaz S., Pazo-Cid R., Del Agua C., Fernández L.J., Ochoa I., Anel A., Martinez-Lostao L.. TRAIL-coated lipid-nanoparticles overcome resistance to soluble recombinant TRAIL in non-small cell lung cancer cells. Nanotechnology. 22 March 2016. DOI: 10.1088/0957-4484/27/18/185101.

Vidal-García M., Domingo M.P., De Rueda B., Roc L., Delgado M.P., Revillo M.J., Pardo J., Gálvez E.M., Rezusta A.. Clinical validity of bis(methylthio)gliotoxin for the diagnosis of invasive aspergillosis. Applied Microbiology and Biotechnology. 1 March 2016. DOI: 10.1007/s00253-015-7209-6.

Torres D., Pinilla J.L., Gálvez E.M., Suelves I.. Graphene quantum dots from fishbone carbon nanofibers. Rsc Advances. 2016. DOI: 10.1039/c6ra09679d.

Alfaro C., Echeveste J.I., Rodriguez-Ruiz M.E., Solorzano J.L., Perez-Gracia J.L., Idoate M.A., Lopez-Picazo J.M., Sanchez-Paulete A.R., Labiano S., Rouzaut A., Oñate C., Aznar A., Lozano M.D., Melero I.. Functional expression of CD137 (4-1BB) on T helper follicular cells. Oncoimmunology. 2 December 2015. DOI: 10.1080/2162402X.2015.1054597.

Ruiz-Garcia R., Mora S., Lozano-Sanchez G., Martinez-Lostao L., Paz-Artal E., Ruiz-Contreras J., Anel A., Gonzalez-Granado L.I., Moreno-Perez D., Allende L.M.. Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation. Pediatric Research. 1 December 2015. DOI: 10.1038/pr.2015.170.

Martínez-Lostao L., Anel A., Pardo J.. How Do Cytotoxic Lymphocytes Kill Cancer Cells?. Clinical Cancer Research. 15 November 2015. DOI: 10.1158/1078-0432.CCR-15-0685.

Sanmamed M.F., Rodriguez I., Schalper K.A., Oñate C., Azpilikueta A., Rodriguez-Ruiz M.E., Morales-Kastresana A., Labiano S., Pérez-Gracia J.L., Martín-Algarra S., Alfaro C., Mazzolini G., Sarno F., Hidalgo M., Korman A.J., Jure-Kunkel M., Melero I.. Nivolumab and urelumab enhance antitumor activity of human T lymphocytes engrafted in Rag2-/-IL2Rγnull immunodeficient mice. Cancer Research. 1 September 2015. DOI: 10.1158/0008-5472.CAN-14-3510.

Anel A., Martínez-Lostao L., Pardo J.. Second meeting of the Spanish immunotherapy group GEIT (grupo español de inmunoterapia), january 16, 2015, in Zaragoza, Spain. Cancer Immunology Immunotherapy. 28 August 2015. DOI: 10.1007/s00262-015-1732-2.

De Miguel D., Gallego-Lleyda A., Galan-Malo P., Rodriguez-Vigil C., Marzo I., Anel A., Martinez-Lostao L.. Immunotherapy with liposome-bound TRAIL overcomes partial protection to soluble TRAIL-induced apoptosis offered by down-regulation of Bim in leukemic cells. Clinical and Translational Oncology. 25 August 2015. DOI: 10.1007/s12094-015-1295-x.